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Summary.-This study was undertaken in an attempt to confirm the increased bile-
acid concentration in association with nuclear dehydrogenating Clostridia (NDC) in
the faeces of colorectal cancer patients. We have studied 37 patients with colorectal
cancer and 36 control patients with no known gastrointestinal disease. Stool speci-
mens were obtained for biochemical analysis (total faecal bile acid (FBA), lithocholic
deoxycholic and cholic acids) and NDC isolation. The mean total FBA concentration
(tmol/g) in the control group was 20-5 + 22 (s.e.) significantly higher (P<0.001) than
the colorectal-cancer group(11-8 +0.7).There wasno statisticallysignificantdifference
in the percentage distribution of the individual FBAs measured. NDC were isolated
from the faeces of640O/ of colorectal-cancer patients and 15% of control patients, this
difference being statistically significant (P<0.001). These results suggest that
bacteria capable of metabolizing steroids may be implicated in the aetiology of
colorectal cancer. However, the relationship between FBA and colorectal cancer
requires further evaluation.
THE INCIDENCE of colorectal cancer
varies widely throughout the world (Doll,
1967, 1969; Doll et al., 1970; Davis et al.,
1965). The disease is commonest in
countries with a "Westernized" civiliza-
tion, and at present Scotland has one of
the highest recorded incidences of colo-
rectal cancer in the world (36.2 per
100,000 population; Calman & Kemp,
1976). Epidemiological studies encom-
passing genetic, cultural, environmental
and economic factors suggest that diet, in
particular an increased intake of fat and
animal protein, correlates best with the
incidence of colorectal cancer (Haenzel et
al., 1975; Buell & Dunn, 1965; Burkitt,
1971; Wynder & Shigematsu, 1967;
Wynder et al., 1969; Gregor et al., 1969).
Although no ingested substance has
been found to be carcinogenic to the large
bowel mucosa (La Mont & O'Gorman,
1978), the observations of the epidemi-
ologists could be explained by the hypo-
thesis put forward by Hill and his col-
leagues (Aries et al., 1969; Hill etal., 19e71).
Hill points out that diet has a significant
influence on the intestinal substrate,
digestive enzymes and large-bowel flora.
He postulates that biochemically active
bacteria in the bowel flora may degrade
the intestinal substrate, thereby producing
carcinogens or co-carcinogens. The bile
acids have been a popular substrate for
investigation, since their faecal content is
related to fat intake (Antonis & Bersohn,
1962) and their acid steroid molecular
structure is not far removed from that of
the polycyclic aromatic carcinogens.
In 1971 Hill and his colleagues published
a study of healthy Scots and Ugandans, a
population with a low incidence of colo-
rectal cancer (Hill & Aries, 1971). They
found that the Scots ate more fat, ex-
creted more acid steroids in their faeces,
degraded their faecal steroids further, and
had more biochemically active anaerobes
in their faeces than the Ugandans.
The bacterium Clostridium paraputrifi-
cum (CPP) was isolated from the faeces of
individuals living in countries with a highW. R. MURRAY ET AL.
incidence of colorectal cancer. This bac-
terium has been shown to be capable of
exhibiting nuclear dehydrogenation
activity, an important step in the degrada-
tion ofthe bile acids (Hill et al., 1971). The
subgroup of CPP exhibiting nuclear de-
hydrogenation activity has been named
NDC, standing for nuclear dehydrogenat-
ing clostridia. In 1975, Hill's group pub-
lished the results of a study of colorectal
cancer patients and controls living in
South-East England. The study showed
that colorectal-cancer patients excreted
significantly more bile acid and NDC in
their faeces than the control group.
The aim of our study was to repeat in
Glasgow, the principal city in an area with
a high incidence of colorectal cancer, the
clinical work of Hill and his colleagues.
PATIENTS AND METHODS
Patients.-We have studied 37 patients
with histologically confirmed colorectal can-
cer admitted to the Western Infirmary,
Glasgow. All patients were recently diagnosed
but none had undergone a barium enema
examination in the 7 days before admission
to hospital. No patient had received an anti-
biotic within one month ofthe study, and no
patient with obstructive symptoms was
included in the study. Twenty-one patients
had a rectal carcinoma while 16 had car-
cinoma of the colon, 8 having tumours
proximal to the mid-point of the transverse
colon. The patients were staged according
to laparotomy findings and histological
examination of the resection specimens or
biopsy material. The patients were classed
as having Stage A tumours when there
was no evidence of full-thickness pene-
tration of the bowel wall by cancer cells;
Stage B tumours when there was full-
thickness penetration, with or without in-
volvement of adjacent structures; Stage C
when tumour spread to lymph nodes was
identified, and Stage D when therewas meta-
static spread to other organs, usually the
liver.
Thirty-six patients (20 males and 16
females) with no known gastrointestinal
disease were also studied as controls. These
control patients were admitted to the
Western Infirmary for elective surgery of
minor conditions such as inguinal and
femoral herniae, simple breast lumps and
varicose veins. Patients were excluded from
the control group if they were found to have
symptoms or signs suggesting gastrointestinal
disease, or if they had received an antibiotic
within one month of admission. All control
patients had lived in the West of Scotland
for the 5 years before the study and all stated
that they were eating a normal diet with no
medically advised or self-imposed restric-
tions.
Faecal samples were obtained from the
first stool passed by each patient following
admission to hospital. About 0 5 g of faeces
was placed in a bijoux bottle containing
4*5 ml of sterile transport medium which
was then stored at -20°C to await bacterio-
logical analysis. The remainder of the faecal
sample was stored in a plastic container at
-20°C to await biochemical analysis.
Biochemical methods.-The method used
for extracting bile acids from the faeces was
based on the technique first described by
Evrard & Janssen (1968) and modified by
Hill & Aries (1971). The deep-frozen faecal
samples were weighed, homogenized with a
known amount of water, and freeze dried.
Steroids were extracted with glacial acetic
acid and toluene. The neutral steroids were
then removed using petroleum ether, and the
bile acids extracted with chloroform. Sodium
borohydride conversion was then carried out
before re-extraction of the bile acids with
ethyl acetate. Total faecal bile-acid (FBA)
was then estimated using the hydroxysteroid
dehydrogenase enzyme assay described by
Iwata & Yamasaki (1964).
Individual bile-acid analysis (lithocholic
deoxycholic and cholic acids) was carried out
using aliquots of total FBA which were
methylated, oxidized with chromic acid and
extracted with diethyl ether. Samples were
re-dissolved in acetone and aliquots injected
for gas-liquid chromatography using a Pye
Unicam instrument (Series 104) with an
O.V.11 column. The detector was set at 275°C
and the column was maintained at 175-180°C
during injection ofthe samples. The tempera-
ture was then rapidly programmed (10°C per
min) up to 250°C for chromatography of the
bile-acid derivatives.
Bacteriological methods.-Clostridium para-
putrificum was isolated by plating out a
faecal suspension on egg-yolk agar and incu-
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bating anaerobically in Robertson's cooked
meat medium. The purity of the isolates was
checked by inoculation on to brain heart
infusion agar plates and aerobic contaminants
were identified by inoculation on to nutrient
agar plates incubated aerobically. The ability
of CPP to metabolize steroids was tested by
incubating a culture in Todd Hewitt broth
containing the substrate 53 androstan-3,
17-dione. The presence of the unsaturated
product A4 androstan-3.17-dione, estimated
by thin-layer chromatography in chloroform
and acetone, indicated a culture ofbiochemic-
ally active CPP (NDC).
RESULTS
The 37 colorectal cancer patients re-
ported in this study are considered to be
representative of patients presenting for
treatment in the West of Scotland with
this disease. The mean age and sex dis-
tribution of the colorectal cancer group
(Table I) are comparable with those of
TABLE I. The number, age and sex dis-
tribution of the patients studied
Patients
Colonic Ca
Rectal Ca
Controls
No. Male Female
16 9 7
21 12) 9
36 20 16
AMean
age
(yrs)
68
65
65
colorectal-cancer patients in similar
studies in England (Hill et al., 1975) and
the U.S.A. (Reddy & Wynder, 1977). The
incidence of chronic irregular bowel habit
(<1 stool per 3 days or regular laxative
use) and a family history of any type of
cancer in the patients with colorectal
cancer is shown in Table II. Two patients
had been resident outside the U.K. for
over 3 months but both had been living in
TABLE II. Clinical details ofthe colorectal-
cancerpatients
Colonic
cancer
- Rectal
R L cancer
n=8 n=8 n=21
Chronic irregular bowel
habit
Family history of cancer
Resident outside U.K.
1
2
1
3
3
0
8
8
1
R=proximal to mid transverse colon.
L = distal to mid transverse colon.
TABLE III.-Staging of the colorectal-cancer
patients (see textfor classification)
Colonic cancer
r- _A-
Stage
A
B
C
D
R
n=8
0
2
3
3
L
n=8
0
3
:3
Rectal
cancer
n=21
7
9
4
Scotland for at least 5 years before the
diagnosis of their colorectal cancer. De-
tails of the staging of the 37 colorectal-
cancer patients are given in Table III. A
full spectrum of tumour spread was
observed, indicating the representative
nature of the sample population.
Total FBA (tmol freeze-dried faeces)
are shown in Table IV. The patients with
colorectal cancer were found to have sig-
nificantly less FBA than the control
patients (P < 0 001). Patients with colonic
cancer and with rectal cancer were found
to have similar total FBA concentrations.
Analysis based on staging of the colorectal
cancer patients as defined above revealed
no statistically significant differences in
total FBA concentration. Males with
colorectal cancer excreted more than
did females with the disease (males 14-3,
TABLE IV. Mean totalfaecal bile acid (FBA) levels andfrequency (mean + s.e.) ofisolation
of Clostridium paraputrificum (CPP) and 1VDC
FBA (,umol/g)
% patients with CPP
patients with NDC
*P<0-001.
Colon
n= 16
13-5 + 13
78
72
Rectum Colo-rectal Controls
n= 21 n=37 n=36
10 6+0-8 11-8+0 7 20-5+2-2*
71 74 31*
57 64 15*
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TABLE V.-Individual faecal bile acids:
Meanpercentage composition ofthefaeces
front colorectal-cancer patients and
controls
Lithocholie 1)eoxycholic Chlolic
acid aci(1 acidi
Colorectal 0/ 475+46 484+3 7 41 +26
n=20
Controls % 4258 + 2 8 572 + 2i9 0
n = 18
females 8.4, P < 0 001). In the control
group, however, no statistically significant
difference was noted between the FBA
output of males and females.
Analyses of the individual bile acids
(lithocholic, deoxycholic and cholic acids)
carried out on faeces from 20 colorectal-
cancer patients and 18 control subjects
are shown in Table V. No statistically sig-
nificant difference was noted in the per-
centage distribution of the 3 FBAs.
Table IV gives details of the percentage
of patients from whom the bacterium
Clostridium paraputrificum (CPP) was
isolated. 7400 of the colorectal-cancer
patients had CPP in their faeces compared
with 31% of control patients (P< 0 001).
64% of the colorectal-cancer patients had
NDC in their faeces compared with 15%
of control subjects (P < 0 001). Analysis
based on staging of the colorectal-cancer
patients showed no statistically significant
difference in percentage NDC isolation.
Eight patients with non-malignant colonic
disease have also been studied and were
found to have a low (25%) incidence of
NDC isolated from their faeces.
DISCUSSION
Hill's finding of significantly increased
total FBA concentrations in patients pre-
senting with colorectal cancer has been
confirmed by Reddy & Wynder (1977).
These authors reported a significant rise
in total FBA when they studied American
Caucasians with colonic cancer and adeno-
matous polyps. No bacteriological evalua-
tion was undertaken in that study, which
remains the only published clinical work
supporting Hill's hypothesis.
In 1977 the Intestinal Microecology
Group of the International Agency for
Research on Cancer reported a detailed
study of sample populations from 2
areas ofDenmark and Finland with a well-
established 4-fold variation in the inci-
dence of colorectal cancer. Total FBA
concentrations were found to be similar in
the 2 populations, and no relationship
was established between cancer incidence
and carriage rates of nuclear dehydrogen-
ating clostridia (NDC). Meat consumption
was greater in the high-incidence area,
whereas higher intakes ofdietary fibre and
milk were noted in the low-incidence area.
Studies from Northern Ireland, an area
with a high incidence of colorectal cancer,
have failed to demonstrate an increased
concentration of total FBA in either
patients with colorectal cancer or patients
at risk of developing this disease (colo-
rectal adenomas, ulcerative colitis and
resected colorectal tumours; Mudd et al.,
1978, 1979). Bacteriological analysis was
not undertaken in these studies. Clearly
the whole question of the association of
colorectal cancer with altered faecal bile-
salt metabolism demands further study.
In this study mean total FBA was found
tobesignificantlyreducedinthe colorectal-
cancer patients, an observation contrary
to that of Hill's group. Samples have been
exchanged between laboratories, and both
groups are satisfied that the difference
observed cannot be explained by experi-
mental error alone. The explanation for
the significant reduction in mean total
FBA in our colorectal-cancer group is
probably complex, but may involve in-
creased breakdown of the bile-acid
steroid molecule in the colon by bacteria.
It is clear however that total FBA was
not raisedinour colorectal-cancer patients,
and there was no evidence that one of the
main individual FBAs was excreted in
greater amounts at the expense of the
other.
The mean total FBA of the control
group of 36 patients with no known
gastrointestinal disease was 20 4 ,tmol/g
faeces. In Hill's study the corresponding
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value for 28 control patients without
gastrointestinal disease was 13-3 pmol/g
(Hill et al., 1975). The 2 control groups
may not be comparable, however, since
Hill does not report the country of origin
or dietary habits of his control patients.
These may be important factors, since it
is known that diet can significantly in-
fluence both colonic bile-acid concentra-
tion and the faecal flora. Hill noted a 21%
incidence of abdominal pain, an 18%
incidence of altered bowel habit and a
14% incidence of bleeding per rectum in
his non-gastrointestinal disease control
group. Patients with any of these symp-
toms were excluded from our control
series to avoid the inclusion of patients
with gastrointestinal disease as yet un-
diagnosed. Despite these possible differ-
ences in the control groups our results
may indicate that the population of the
West of Scotland excrete more FBA than
their counterparts in South-East England.
This finding could be related to different
dietary habits in these 2 areas. A mean
FBA concentration of 28-1 tmol/g has
been reported from 19 control patients in
Northern Ireland (Mudd et al., 1979). It is
interesting to note that the incidence of
colorectal cancer in both the West of
Scotland and Northern Ireland is greater
than that recorded in the South-East of
England (Calman & Kemp, 1976).
The significant increase in the isolation
of NDC from faeces of colorectal-cancer
patients supports the findings of Hill's
group. As a result ofthe presence ofNDC,
steroid metabolism in the faeces of these
patients might be enhanced, possibly
leading to the formation of carcinogens or
co-carcinogens as yet unidentified. This
hypothesis could also explain the reduc-
tion in total FBA in patients with colo-
rectal cancer. It is of course possible that
the increased NDC isolation was secondary
to the presence of the colorectal cancer,
and not related in any way to its
induction.
We have shown that control patients in
the West of Scotland excrete considerable
amounts of bile acid in their faeces and
that this excretion is significantly reduced
in patients with colorectal cancer. The
presence of large amounts of bile acid in
the colon may greatly increase the im-
portance of the biochemically active
bacteria in the colonic flora. One of these
bacteria (NDC) has been isolated more
frequently from the faeces ofpatients with
colorectal cancer than from the faeces of
control patients. Increased bacterial
degradation of the colonic bile acids
should result in less measureable bile acid
in the faeces. This has been found in our
study, but the nature of the degradation
products remains unidentified.
Although bile-acid degradation may
produce carcinogenic substances in vitro,
a carcinogen has yet to be isolated from
human faeces (La Mont & O'Gorman,
1978). The measurement of the common
FBAs alone may not prove to be of value
in detecting patients at risk of colorectal
cancer. The search for carcinogenic degra-
dation products in the faeces must con-
tinue, in the hope of isolating a more
specific marker which might be in-
criminated in the aetiology of colorectal
cancer.
This study was supported by a grant from the
Cancer Research Campaign.
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